Cefazaflur
Cefazaflur is a cephalosporin antibiotic that is used in the treatment of various bacterial infections. It belongs to the third generation of cephalosporins and is known for its broad-spectrum activity against a wide range of bacteria.
Mechanism of Action[edit | edit source]
Cefazaflur works by inhibiting the synthesis of the bacterial cell wall. It binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding leads to the inhibition of the third and last stage of bacterial cell wall synthesis, which ultimately causes cell lysis.
Pharmacokinetics[edit | edit source]
After oral administration, Cefazaflur is rapidly absorbed from the gastrointestinal tract. It is widely distributed in body tissues and fluids. The drug is primarily excreted unchanged in the urine.
Clinical Uses[edit | edit source]
Cefazaflur is used to treat a variety of bacterial infections, including those caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is also effective against certain Gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Side Effects[edit | edit source]
Common side effects of Cefazaflur include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, it can cause serious side effects like allergic reactions, kidney damage, and blood disorders.
Contraindications[edit | edit source]
Cefazaflur is contraindicated in patients with a known allergy to cephalosporin antibiotics. It should be used with caution in patients with a history of kidney disease or gastrointestinal disease.
Drug Interactions[edit | edit source]
Cefazaflur may interact with other drugs like probenecid, warfarin, and aminoglycosides. Therefore, it is important to inform the healthcare provider about all the medications being taken before starting treatment with Cefazaflur.
- Cefaclor (2nd)
- Cefadroxil (1st)
- Cefdinir (3rd)
- Cefditoren (3rd)
- Cefixime (3rd)
- Cefpodoxime (3rd)
- Cefprozil (2nd)
- Ceftibuten (1st)
- Cephalexin (1st)
- Cefuroxime (2nd)
- Cephradine (1st)
- Loracarbef (2nd)
- Cefazolin (1st)
- Cefepime (4th)
- Cefoperazone (3rd)
- Cefotaxime (3rd)
- Cefoxitin (2nd)
- Ceftaroline (5th)
- Ceftazidime (3rd)
- Ceftibuten (3rd)
- Ceftizoxime (3rd)
- Ceftolozane/Tazobactam (5th)
- Cefuroxime (2nd)
- Cephradine (1st)
- Ceftriaxone (3rd)
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD